Search

» » » Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily

Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily

Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents  Investor's Business Daily

Alexion stock crashed Friday after officials agreed to review Amgen's challenge to the patents covering Alexion's blockbuster drug, Soliris.

View full coverage on Google News
Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily
Read More


Bagikan Berita Ini

Related Posts :

0 Response to "Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily"

Post a Comment

Subscribe to: Post Comments (Atom)
Powered by Blogger.